DERM
Journey Medical Corp
6.50$
-10.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -55.8% | -14.6% | +14.0% | -1.5% | -6.9% | -3.5% | +14.2% | +17.5% | -8.8% | -0.7% | +16.0% | – | |
| – | -6.4% | +13.3% | -4.0% | -19.2% | -57.7% | +161.7% | +2.5% | -4.1% | +13.0% | +12.9% | -16.4% | – | |
| – | -67.1% | -32.8% | +33.8% | +12.4% | +21.8% | -36.0% | +23.6% | +31.9% | -19.4% | -10.0% | +43.5% | – | |
| – | -32.5% | +423.9% | -88.4% | -7.8% | -74.1% | -82.1% | -100.0% | – | -46.3% | -100.0% | – | – | |
| – | +40.6% | -30.6% | +22.7% | +10.3% | -11.7% | +5.1% | +12.4% | +1.4% | -18.2% | +2.5% | +7.7% | – | |
| – | +4.4% | +43.7% | -31.1% | +8.9% | -25.2% | +15.9% | +12.0% | +12.8% | -25.3% | +0.9% | +17.8% | – | |
| – | -112.2% | – | – | – | – | -248.8% | – | – | – | – | – | – | |
| – | -91.0% | +2,183.3% | +2.7% | +34.6% | +9.6% | +7.2% | +5.2% | +0.0% | -0.4% | -4.4% | +1.6% | – | |
| – | -111.9% | – | – | – | – | -357.5% | – | – | – | – | – | – | |
| – | +32.6% | +529.1% | – | – | – | – | – | – | – | – | – | – | |
| – | -112.8% | – | – | – | – | -367.8% | – | – | – | – | – | – | |
| – | -106.4% | – | – | – | – | -161.4% | – | – | – | -124.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.